Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor
Anna Laura Di Pace, Nicola Tumino, Francesca Besi, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 661-661
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Exosome-based immunotherapy: a promising approach for cancer treatment
Zhijie Xu, Shuangshuang Zeng, Zhicheng Gong, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 363
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications
Ali Hazrati, Sara Soudi, Kosar Malekpour, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 91
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 72
NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions
Heyong Luo, Yanhua Zhou, Jing Zhang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 48
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 47
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 38
Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications
Chunhao Yang, Yunxin Xue, Yu Duan, et al.
Journal of Controlled Release (2024) Vol. 365, pp. 1089-1123
Closed Access | Times Cited: 31
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
Junli Lu, Yiming Luo, Dean Rao, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Communication is key: extracellular vesicles as mediators of infection and defence during host–microbe interactions in animals and plants
Henrik U. Stotz, Dominik Brotherton, Jameel M. Inal
FEMS Microbiology Reviews (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 81
On‐Chip Biogenesis of Circulating NK Cell‐Derived Exosomes in Non‐Small Cell Lung Cancer Exhibits Antitumoral Activity
Yoon‐Tae Kang, Zeqi Niu, Thomas Hadlock, et al.
Advanced Science (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 76
Exosome: A New Player in Translational Nanomedicine
Houssam Aheget, María Tristán‐Manzano, Loubna Mazini, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2380-2380
Open Access | Times Cited: 73
Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy
Feifeng Wu, Min Xie, Marady Hun, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Exosome as a Delivery Vehicle for Cancer Therapy
Bo‐Hyun Moon, Suhwan Chang
Cells (2022) Vol. 11, Iss. 3, pp. 316-316
Open Access | Times Cited: 64
Conscription of Immune Cells by Light‐Activatable Silencing NK‐Derived Exosome (LASNEO) for Synergetic Tumor Eradication
Jun Zhang, Wanxuan Shao, Tongren Yang, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 58
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges
Fang Yang, Jing Ni, Yun-Sheng Wang, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 3, pp. 103260-103260
Closed Access | Times Cited: 57
Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT
Nicola Tumino, Anna Laura Di Pace, Francesca Besi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer
Kübra Kaban, Clemens Hinterleitner, Yanjun Zhou, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 56
Application of engineered extracellular vesicles for targeted tumor therapy
Fusheng Zhang, J.J. Guo, Zhenghou Zhang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 52
Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses
Sara G. Dosil, Sheila López‐Cobo, Ana Rodríguez‐Galán, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 49
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Shweta Joshi, Andrew B. Sharabi
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108114-108114
Open Access | Times Cited: 47
Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
Wu Manling, Min Wang, Haoyuan Jia, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2513-2538
Open Access | Times Cited: 47
Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models
Ho Yong Kim, Hyun-Ki Min, Hyeong‐Woo Song, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2897-2911
Open Access | Times Cited: 44
Exosomes in cancer immunoediting and immunotherapy
Yarong Zhao, Luotong Liu, Rongze Sun, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 2, pp. 193-205
Open Access | Times Cited: 37
Exosome regulation of immune response mechanism: Pros and cons in immunotherapy
Julien Milon Essola, Jun Zhang, Haiyin Yang, et al.
Bioactive Materials (2023) Vol. 32, pp. 124-146
Open Access | Times Cited: 33
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment
Faride Nam Avar Jahromi, Razieh Dowran, Reza Jafari
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top